References
- Dorfman H D, Czerniak B. Bone tumors. Mosby, St. Louis 1998; 441–481
- Yang Y H, Xie G, Wang A Q, et al. Fibrous dysplasia with malignant tansformation- a case report and review of the literature. Chin J Bone Tumor Bone Dis 2003; 2: 2114–2116
- Yu Y W, Zhu M H, Lin W H, et al. Fibrous dysplasia with sarcomatous transformation: a case report. Acad J Sec Mil Med Univ 2006; 27: 3
- Yabut S M, Jr, Kenan S, Sissons H A, et al. Malignant transformation of fibrous dysplasia. A case report and review of the literature. Clin Orthop Relat Res 1988; 228: 281–289
- Ruggieri P, Sim F H, Bond J R, et al. Malignancies in fibrous dysplasia. Cancer 1994; 73: 1411–1424
- Hoshi M, Matsumoto S, Manabe J, et al. Malignant change secondary to fibrous dysplasia. Int J Clin Oncol 2006; 11: 229–235
- Ishida T, Machinami R, Kojima T, et al. Malignant fibrous histiocytoma and osteosarcoma in association with fibrous dysplasia of bone. Report of three cases. Pathol Res Pract 1992; 188: 757–763
- Unni K K. Dahlin's Bone Tumors. General Aspects and Data on 11,087 Cases. Lippincott-Raven, Philadelphia 1996; 367–376
- Mikami M, Koizumi H, Ishii M, et al. The identification of monoclonality in fibrous dysplasia by methylation-specific polymerase chain reaction for the human androgen receptor gene. Virchows Archiv 2004; 444: 56–60
- Diao X L, Su Q, Wang S F, et al. Non-isotopic clonality analysis on uterine leiomyomas based on AR gene polymorphism. J Fourth Mil Med Univ 2002; 23: 1969–1973
- Wang S F, Liu Q, Zhang W, et al. Clonality of uterine leiomyomas, an assay using X xhromosome polymorphism at the phosphoglycerate kinase locus. J Fourth Mil Med Univ 2001; 22: 1576–1582
- Hempel J M, Karkos P D, Issing W J. Fibrous dysplasia of the frontal bone. Ear Nose Throat J 2006; 85: 654–657
- Liu C. Advancement of pathogenesis and treatment of fibrous dysplasia. Orthop J Chin 2001; 10: 1002–1003
- Riminucci M, Saggio I, Robey P G, et al. Fibrous dysplasia as a stem cell disease. J Bone Miner Res 2006; 21: 125–131
- Dal Cin P, Sciot R, Brys P, et al. Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. Chromosomes and morphology. Cancer Genet Cytogenet 2000; 122: 30–32
- Weinstein L S, Shenker A, Gejman P V, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688–1695
- Candeliere G A, Glorieux F H, Prud'homme J, et al. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995; 332: 1546–1551
- Su Q. Preneoplastic lesion of human heaptocellular carcinoma. Chin J Diagn Pathol 2003; 10: 112–115
- Lyon M F. X-chromosome inactivation and developmental patterns in mammals. Biol Rev Camb Philos Soc 1972; 47: 1–35
- Gilliland D G, Blanchard K L, Levy J, et al. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 1991; 88: 6848–6852
- Allen R C, Zoghbi H Y, Moseley A B, et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet 1992; 51: 1229–1239
- Su Q, Liu Q, Wang S F. Clonality analysis technique based on X chromosome genetic polymorphism and application. Zhonghua Bing Li Xue Zazhi 2002; 31: 162–164
- Nesbitt M N. Chimeras vs X inactivation mosaics: significance of differences in pigment distribution. Dev Biol 1974; 38: 202–207